consulting

As a UCSF physician-scientist specializing in rare lipid disorders, I partner with pharmaceutical and biotech companies to guide the development of novel therapeutics.

My consulting expertise includes:

• Clinical Trial Strategy: Guiding pediatric and adult metabolic clinical trials, study design, and research initiatives.
• Translational Insights: Bridging the gap between advanced metabolic pathways, RNA-targeted therapeutics, immunology, and clinical practice.
• Rare Disease Focus: Specialized knowledge in complex conditions like Familial Chylomicronemia Syndrome (FCS) and Homozygous/Heterozygous Familial Hypercholesterolemia (HoFH/HeFH).